OAKIX | QFVIX | OAKIX / QFVIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 32 years | 26 years | - |
Gain YTD | -5.887 | 2.524 | -233% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 16.9B | 2.69B | 628% |
Annual Yield % from dividends | 1.84 | 2.20 | 84% |
Returns for 1 year | 1.42 | 10.23 | 14% |
Returns for 3 years | -8.98 | 3.62 | -248% |
Returns for 5 years | 8.36 | 21.05 | 40% |
Returns for 10 years | 6.90 | 44.72 | 15% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
RSPD | 54.26 | 0.81 | +1.52% |
Invesco S&P 500® Equal Wt Cnsm Disc ETF | |||
FBT | 168.85 | 2.39 | +1.44% |
First Trust NYSE Arca Biotech ETF | |||
MMSC | 22.50 | 0.30 | +1.35% |
First Trust Multi-Manager Sm Cp Opps ETF | |||
SCHG | 27.49 | 0.04 | +0.15% |
Schwab US Large-Cap Growth ETF™ | |||
IBHI | 23.68 | -0.02 | -0.11% |
iShares iBonds 2029 Term HY & Inc ETF |